Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2019-11-19
2020-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotic Supplementation and Endurance Performance in Cyclists and Masters Runners
NCT02756221
The Effect of Prebiotics on Endurance Performance
NCT04946578
Efficacy of Probiotics on Physical Performance
NCT03259997
Effect of Probiotics on Endurance Athletes' Microbiome at Rest and Post-race
NCT05615961
Efficacy of a Mix of Probiotics in Athletes Performance
NCT06093139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective:
Primary Objective:
Can the chance at and/or intensity of gastrointestinal symptoms during exercise be influenced by probiotics supplementation in trained endurance athletes who experience these symptoms and can performance be enhanced? Secondairy Objective: Can the composition and function of the gut microbiota of trained athletes that experience gastrointestinal symptoms during exercise be positively influenced by probiotics supplementation?
Study design: A double-blind randomized placebo-controlled trial will be performed to investigate the effect of 14 weeks probiotics supplementation with Ecologic® PERFORMANCE supplements. Standardized maximal incremental exercise tests will be performed before and after the supplementation period, as well as two performance tests (before) and one performance test (after). During the supplementation period training diaries, a POMS questionnaire and some questionnaires about food habits will be completed, a food diary and Food Frequency Questionnaire (FFQ).
Study population: Healthy male endurance athletes of Dutch nationality, 18-45 years old, who regularly experience gastrointestinal symptoms during exercise.
Intervention: Fourteen weeks of supplementation with Ecologic® PERFORMANCE probiotics supplements (or placebo).
Main study parameters/endpoints: Main study endpoints are differences in changes in the severity and occurrence of gastrointestinal symptoms and changes in exercise performance (total distance on a time trial and maximum speed during an incremental exercise test). Also changes in composition of the microbiota and differences in changes in the metabolites in the stool sample before and after the supplementation period in the experimental and control group will be studied.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Benefits will be the value of the test results and outcome measures of the microbiome analysis. Also the chance on a reduced risk of occurrence of gastrointestinal symptoms might be of value for potential participants. The risks for the participants are minor. Only participants that are healthy and endurance trained will be included. In the Human Performance Laboratory of the Faculty of Behavioural and Human Movement Sciences, performance tests in warm conditions are executed regularly and health risks related to the experimental protocol are minor for the participants since they are already well-trained and the exercise intensity will be relatively well-tolerated, since they are used to similar efforts. Probiotics supplements are freely available at the market, and the Ecologic® PERFORMANCE supplements are available in the web shop of Winclove B.V. The same supplement has been used before in the same dosage and no adverse effects were reported. Participants will fill in a food frequency questionnaire and questionnaire about gastrointestinal symptoms and hand in a stool sample before and after the supplementation period. They will be asked to maintain a training diary during the supplementation period and also fill in the POMS questionnaire weekly. The maximal incremental exercise test (2 times) consists of a warming-up followed by incremental increase in running velocity until voluntary exhaustion. The performance tests (3 times) consists of 60 minutes of submaximal running followed by a time trial of 30 minutes in which participants need to accomplish as much distance as possible.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotics:Healthy male endurance athletes with GI symptoms
14 weeks of supplementation with a multispecies probiotics: Ecologic® PERFORMANCE ( 1\*1010 CFU(Colony forming units)/daily dose, Winclove Probiotics B.V., Amsterdam).
Ecologic® PERFORMANCE
Ecologic® PERFORMANCE is a probiotic formulation consisting of different probiotic bacterial strains, namely:
Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Enterococcus faecium W54 Lactobacillus acidophilus W22 Lactobacillus brevis W63 Lactococcus lactis W58
Except for the bacterial strains, Ecologic® PERFORMANCE contains the following other ingredients:
* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)
Placebo: Healthy male endurance athletes with GI symptoms
14 weeks of supplementation with a placebo comparator (Winclove Probiotics B.V., Amsterdam)
Placebo
The placebo contains no bacterial strains, but the following ingredients:
* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ecologic® PERFORMANCE
Ecologic® PERFORMANCE is a probiotic formulation consisting of different probiotic bacterial strains, namely:
Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Enterococcus faecium W54 Lactobacillus acidophilus W22 Lactobacillus brevis W63 Lactococcus lactis W58
Except for the bacterial strains, Ecologic® PERFORMANCE contains the following other ingredients:
* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)
Placebo
The placebo contains no bacterial strains, but the following ingredients:
* maize starch and maltodextrins
* fructo-oligosaccharides (FOS) P6 and Polydextrose P4 (strain specific prebiotics)
* vegetable protein
* mineral mix (Potassium chloride, Magnesium sulphate, Manganese sulphate)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* an average training frequency of at least three times per week;
* a low risk profile based on a health-history form (the form is attached to the participant information letter);
* occurrence of exercise-induced gastrointestinal symptoms.
Exclusion Criteria
* a diagnosis of gastrointestinal disorders (e.g. Crohn's disease, celiac disease, diagnosed with irritable bowel syndrome);
* use of antidepressants in the 6 months prior to the start of the study;
* use of antibiotics, antivirals, antifungals, antiparasitic agents, prebiotics/probiotics supplements (foods are allowed) in the 6 months prior to the start of the study.
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VU University of Amsterdam
OTHER
Wageningen University and Research
OTHER
Universiteit Leiden
OTHER
MyMicroZoo
UNKNOWN
Winclove Bio Industries BV
INDUSTRY
Karlijn te Poele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karlijn te Poele
MSc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karlijn te Poele, MSc
Role: PRINCIPAL_INVESTIGATOR
Hogeschool Leiden, University of Applied Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vrije Universiteit Amsterdam
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL69974.081.19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.